Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leveraging premalignant biology for immune-based cancer prevention

16 Sept 2016

Abstract excerpt

Prevention is an essential component of cancer eradication. Next-generation sequencing of cancer genomes and epigenomes has defined large numbers of driver mutations and molecular subgroups, leading to therapeutic advances. By comparison, there is a relative paucity of such knowledge in premalignant neoplasia, which inherently limits the potential to develop precision prevention strategies. Studies on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Hepatitis B Virus Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27638202
DOI: 10.1073/pnas.1608077113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leveraging premalignant biology for immune-based cancer preventionPMID 27638202Read ↗

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.Semantic proximity Read ↗

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?Semantic proximity Read ↗

Precancer Atlas to Drive Precision Prevention Trials.Semantic proximity Read ↗

Advances and challenges in cancer immunoprevention and immune interception.Semantic proximity Read ↗

The hallmarks of premalignant conditions: a molecular basis for cancer prevention.Semantic proximity Read ↗

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategiesSemantic proximity Read ↗

The Case for a Pre-Cancer Genome Atlas (PCGA)Semantic proximity Read ↗

Lynch Syndrome: From Carcinogenesis to Prevention InterventionsSemantic proximity Read ↗

Vaccines for immunoprevention of DNA mismatch repair deficient cancersSemantic proximity Read ↗

Translating Germline Cancer Risk into Precision Prevention.Semantic proximity Read ↗

Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention.Semantic proximity Read ↗

Genetic Changes Driving Immunosuppressive Microenvironments in Oral PremalignancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.